Gainers
- HeartBeam BEAT stock rose 20.1% to $2.42 during Thursday's pre-market session. The company's market cap stands at $62.6 million.
- Prelude Therapeutics PRLD shares increased by 11.43% to $5.75. The market value of their outstanding shares is at $275.7 million.
- Benitec Biopharma BNTC shares rose 10.36% to $0.23. The market value of their outstanding shares is at $6.4 million.
- Predictive Oncology POAI shares moved upwards by 10.19% to $3.46. The market value of their outstanding shares is at $13.8 million.
- Bullfrog AI Hldgs BFRG stock increased by 9.71% to $5.42. The company's market cap stands at $32.9 million. The company's, Q1 earnings came out yesterday.
- Cardio Diagnostics Hldgs CDIO shares increased by 9.16% to $1.44. The market value of their outstanding shares is at $14.3 million.
Losers
- Biocept BIOC stock declined by 42.1% to $2.46 during Thursday's pre-market session. The company's market cap stands at $1.4 million.
- Annexon ANNX stock declined by 34.24% to $3.4. The company's market cap stands at $180.4 million.
- Enveric Biosciences ENVB stock declined by 14.97% to $4.09. The company's market cap stands at $8.5 million.
- Minerva Surgical UTRS shares declined by 11.99% to $0.29. The company's market cap stands at $51.8 million.
- BiomX PHGE shares declined by 11.43% to $0.31. The company's market cap stands at $14.2 million.
- Apexigen APGN stock decreased by 11.11% to $0.52. The company's market cap stands at $12.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ANNXAnnexon Inc
$2.410.42%
Edge Rankings
Momentum
6.66
Price Trend
Short
Medium
Long
BEATHeartBeam Inc
$1.26-0.79%
BFRGBullfrog AI Holdings Inc
$1.49-%
BNTCBenitec Biopharma Inc
$11.75-%
CDIOCardio Diagnostics Holdings Inc
$4.60-%
ENVBEnveric Biosciences Inc
$1.24-1.59%
PHGEBiomX Inc
Not Available-%
POAIPredictive Oncology Inc
$0.81203.66%
PRLDPrelude Therapeutics Inc
$0.85344.06%
UTRSMinerva Surgical Inc
$0.00010-100.0%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.